Inhibikase Therapeutics, Inc. (IKT)
Inhibikase Therapeutics, Inc. (IKT) has reported earnings 6 times since Nov 17, 2022. The stock moves an average of ±2.88% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +3.6% (Nov 17, 2022) and its largest decline was -4.25% (May 14, 2025).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
6
Avg Abs. Movement
±2.88%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | ☽ POST | $1.61 | $1.69 | $1.63 | 551,600 | +3.07% | open_in_new |
| Nov 14, 2025 | ☽ POST | $1.57 | $1.63 | $1.53 | 76,800 | -0.65% | open_in_new |
| Aug 14, 2025 | ☽ POST | $1.70 | $1.79 | $1.71 | 81,200 | +2.34% | open_in_new |
| May 14, 2025 | ☽ POST | $2.27 | $2.27 | $2.12 | 91,300 | -4.25% | open_in_new |
| Mar 27, 2025 | ☽ POST | $2.42 | $2.42 | $2.37 | 134,100 | -3.38% | open_in_new |
| Nov 17, 2022 | ☽ POST | $3.70 | $4.50 | $4.17 | 39,833 | +3.6% | open_in_new |
Earnings Count
6
Total earnings in dataset
Avg Abs. Movement
±2.88%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| ARS | 20260430 | open_in_new SEC.gov |
| DEF 14A | 20260430 | open_in_new SEC.gov |
| DEFA14A | 20260430 | open_in_new SEC.gov |
| PRE 14A | 20260420 | open_in_new SEC.gov |
| 8-K | 20260407 | open_in_new SEC.gov |
| S-8 | 20260326 | open_in_new SEC.gov |
Frequently asked about IKT earnings
How much does IKT stock move after earnings? expand_more
Over 6 reports, IKT has moved an average of ±2.88% the session after earnings, closing higher 50.0% of the time.
What was IKT's biggest post-earnings move? expand_more
IKT's largest post-earnings gain on record was +3.6% on Nov 17, 2022, and its largest decline was -4.25% on May 14, 2025.
Where can I find Inhibikase Therapeutics, Inc.'s SEC filings? expand_more
All of Inhibikase Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right